Introduction {#H1-1-ZOI190666}
============

*Clostridium difficile* (also known as *Clostridioides difficile*) is the most common pathogen causing health care--associated infections in the United States, accounting for 15% of all such infections.^[@zoi190666r1]^ A Centers for Disease Control and Prevention report on antibiotic resistance threats categorized *C difficile* as an urgent threat.^[@zoi190666r2]^ Antibiotic treatment for *C difficile* infection (CDI) is often followed by recurrent infection, leading to nontraditional treatments, such as fecal transplant and oral administration of nontoxigenic *C difficile* spores.^[@zoi190666r3],[@zoi190666r4]^

Information about the burden of CDI in the United States could inform investments in prevention and treatment interventions. This information should include the incidence of CDI, how this incidence has changed over time, and poor outcomes associated with CDI. Although prior studies have shown that CDI is associated with poor outcomes, such as recurrence, long hospital length of stay (LOS), mortality, and high treatment costs, these results vary by study location and patient population.^[@zoi190666r2],[@zoi190666r5]^ In addition, many current estimates of the poor outcomes and costs associated with CDI do not take into account the underlying severity of illness among patients who develop CDI and may overestimate the true attributable outcomes.^[@zoi190666r6]^

To address gaps in our understanding of the current burden associated with CDI in the United States, we conducted a systematic literature review of studies conducted in the United States and published after 2000 that evaluated the incidence of CDI and associated LOS. The goals were to describe the recent incidence of CDI and to evaluate LOS attributable to CDI.

Methods {#H1-2-ZOI190666}
=======

Search Strategy {#H2-1-ZOI190666}
---------------

This systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses ([PRISMA](http://www.equator-network.org/reporting-guidelines/prisma/))^[@zoi190666r7]^ and Meta-analysis of Observational Studies in Epidemiology ([MOOSE](https://www.equator-network.org/reporting-guidelines/meta-analysis-of-observational-studies-in-epidemiology-a-proposal-for-reporting-meta-analysis-of-observational-studies-in-epidemiology-moose-group/))^[@zoi190666r8]^ reporting guidelines. An experienced health sciences librarian (A.B.) conducted systematic searches in MEDLINE via Ovid, Cochrane Library Databases via Wiley, Cumulative Index of Nursing and Allied Health Complete via EBSCO Information Services, Scopus, and Web of Science to identify articles published from the inception of the database to February 2019. Citations published before 2000 were excluded. A combination of keywords and subject headings were used for "*Clostridium difficile*," "length of stay," and "incidence." The full search strategies can be found in eAppendix 1 in the [Supplement](#note-ZOI190666-1-s){ref-type="supplementary-material"}.

Inclusion and Exclusion Criteria {#H2-2-ZOI190666}
--------------------------------

Publications were included if they evaluated the incidence of CDI or LOS associated with CDI. Studies were excluded if they did not contain original data, did not have a control group, were published outside the United States, were published in a language other than English, or were published before 2000. The year 2000 was chosen as the beginning of this systematic literature review because that was when the epidemic BI/NAP1/027 strain of *C difficile* emerged, after which CDI increased in prevalence and became less responsive to treatment.^[@zoi190666r4]^ We excluded studies if they assessed only a specific subset of patients, unless that population could be categorized as 1 of the following subsets: immunocompromised patients, patients in the intensive care unit, patients with cancer, patients with end-stage renal disease, patients undergoing hemodialysis, surgical patients, solid-organ transplant recipients, patients with high-risk gastrointestinal conditions, or peripartum women. We excluded studies with a study period of less than 1 year. We also excluded studies of long-term care facilities. Incidence data were collected only from multicenter studies that had at least 5 sites, because single-site or small studies may be biased by outbreaks or other local conditions. We included incidence studies with denominators of patient-days or person-years, known timing of the CDI such as after surgery or after admission (ie, hospital onset \[HO\]), or exclusion of patients with a history of CDI.

Studies were included in the LOS analysis only if they provided data on postinfection LOS, if they used methods accounting for time to infection using a multistate model, or if propensity score--matched patients with CDI were compared with uninfected controls.^[@zoi190666r5],[@zoi190666r9]^ Studies were excluded if they did not have an uninfected control group or a denominator that included patients without CDI.

Data Extraction and Quality Assessment {#H2-3-ZOI190666}
--------------------------------------

Titles and abstracts of all articles were screened to assess inclusion criteria. Two of 9 independent reviewers (M.L.S., M.A.W., M.F.K., H.-Y.C., M.L.C., L.A.H., D.J.D., A.R.M., and E.N.P.) abstracted data for each article. Reviewers resolved disagreements by consensus.

The reviewers abstracted data on study design, study population, setting and years, inclusion and exclusion criteria, number of patients included, description of control group, definition of CDI, outcomes (eg, incidence and LOS), and an assessment of the potential risk of bias. Risk of bias was assessed using the Downs and Black scale.^[@zoi190666r10]^ Reviewers followed all questions from this scale as written except for question 27 (a single item on the Power subscale, which was scored 0-5), which was changed to a yes or no. Two of us (A.R.M. and M.L.S.) performed component quality analysis independently, reviewed all inconsistent assessments, and resolved disagreements by consensus.^[@zoi190666r11]^

Statistical Analysis {#H2-4-ZOI190666}
--------------------

Data analysis was performed in February 2019. Excel spreadsheet software version 2007 (Microsoft Corp) and RevMan statistical software version 5.3 (Cochrane Community) were used for statistical analysis. Incidence data were pooled only when the denominators used the same units (eg, patient-days). These data were pooled by summing the number of HO-CDI incident cases and the denominators across studies. Pooled incidence was reported as the number of incident cases per the given denominator (eg, 10 000 patient-days).^[@zoi190666r12]^ No *P* values were calculated.

Results {#H1-3-ZOI190666}
=======

Of the 34 775 articles identified ([Figure](#zoi190666f1){ref-type="fig"}), 119 were full-text articles, and 86 (72.3%) of those articles met the selection criteria and were included in the systematic literature review.^[@zoi190666r13],[@zoi190666r14],[@zoi190666r15],[@zoi190666r16],[@zoi190666r17],[@zoi190666r18],[@zoi190666r19],[@zoi190666r20],[@zoi190666r21],[@zoi190666r22],[@zoi190666r23],[@zoi190666r24],[@zoi190666r25],[@zoi190666r26],[@zoi190666r27],[@zoi190666r28],[@zoi190666r29],[@zoi190666r30],[@zoi190666r31],[@zoi190666r32],[@zoi190666r33],[@zoi190666r34],[@zoi190666r35],[@zoi190666r36],[@zoi190666r37],[@zoi190666r38],[@zoi190666r39],[@zoi190666r40],[@zoi190666r41],[@zoi190666r42],[@zoi190666r43],[@zoi190666r44],[@zoi190666r45],[@zoi190666r46],[@zoi190666r47],[@zoi190666r48],[@zoi190666r49],[@zoi190666r50],[@zoi190666r51],[@zoi190666r52],[@zoi190666r53],[@zoi190666r54],[@zoi190666r55],[@zoi190666r56],[@zoi190666r57],[@zoi190666r58],[@zoi190666r59],[@zoi190666r60],[@zoi190666r61],[@zoi190666r62],[@zoi190666r63],[@zoi190666r64],[@zoi190666r65],[@zoi190666r66],[@zoi190666r67],[@zoi190666r68],[@zoi190666r69],[@zoi190666r70],[@zoi190666r71],[@zoi190666r72],[@zoi190666r73],[@zoi190666r74],[@zoi190666r75],[@zoi190666r76],[@zoi190666r77],[@zoi190666r78],[@zoi190666r79],[@zoi190666r80],[@zoi190666r81],[@zoi190666r82],[@zoi190666r83],[@zoi190666r84],[@zoi190666r85],[@zoi190666r86],[@zoi190666r87],[@zoi190666r88],[@zoi190666r89],[@zoi190666r90],[@zoi190666r91],[@zoi190666r92],[@zoi190666r93]^ Among these, 66 articles evaluated incidence,^[@zoi190666r13],[@zoi190666r14],[@zoi190666r15],[@zoi190666r16],[@zoi190666r17],[@zoi190666r18],[@zoi190666r19],[@zoi190666r20],[@zoi190666r21],[@zoi190666r22],[@zoi190666r23],[@zoi190666r24],[@zoi190666r25],[@zoi190666r26],[@zoi190666r27],[@zoi190666r28],[@zoi190666r29],[@zoi190666r30],[@zoi190666r31],[@zoi190666r32],[@zoi190666r33],[@zoi190666r34],[@zoi190666r35],[@zoi190666r36],[@zoi190666r37],[@zoi190666r38],[@zoi190666r39],[@zoi190666r40],[@zoi190666r41],[@zoi190666r42],[@zoi190666r43],[@zoi190666r44],[@zoi190666r45],[@zoi190666r46],[@zoi190666r47],[@zoi190666r48],[@zoi190666r49],[@zoi190666r50],[@zoi190666r51],[@zoi190666r52],[@zoi190666r53],[@zoi190666r54],[@zoi190666r55],[@zoi190666r56],[@zoi190666r57],[@zoi190666r58],[@zoi190666r59],[@zoi190666r60],[@zoi190666r61],[@zoi190666r62],[@zoi190666r63],[@zoi190666r64],[@zoi190666r65],[@zoi190666r66],[@zoi190666r67],[@zoi190666r68],[@zoi190666r69],[@zoi190666r70],[@zoi190666r71],[@zoi190666r72],[@zoi190666r73],[@zoi190666r74],[@zoi190666r75],[@zoi190666r76],[@zoi190666r77],[@zoi190666r78]^ and 20 articles evaluated LOS.^[@zoi190666r16],[@zoi190666r54],[@zoi190666r66],[@zoi190666r79],[@zoi190666r80],[@zoi190666r81],[@zoi190666r82],[@zoi190666r83],[@zoi190666r84],[@zoi190666r85],[@zoi190666r86],[@zoi190666r87],[@zoi190666r88],[@zoi190666r89],[@zoi190666r90],[@zoi190666r91],[@zoi190666r92],[@zoi190666r93],[@zoi190666r94],[@zoi190666r95]^ One-fifth of the studies that assessed LOS (4 studies)^[@zoi190666r84],[@zoi190666r87],[@zoi190666r91],[@zoi190666r94]^ scored 18 or more points of the 28 points possible on the Downs and Black scale^[@zoi190666r10]^ and, thus, were considered to be of higher quality.

![Literature Search for Articles That Evaluated Incidence and Length of Stay (LOS) Associated With *Clostridium difficile* Infection\
CINAHL indicates Cumulative Index of Nursing and Allied Health.](jamanetwopen-3-e1917597-g001){#zoi190666f1}

Incidence of CDI Calculated Using Patient-Days (13 Studies) {#H2-5-ZOI190666}
-----------------------------------------------------------

Sixty-six studies^[@zoi190666r13],[@zoi190666r14],[@zoi190666r15],[@zoi190666r16],[@zoi190666r17],[@zoi190666r18],[@zoi190666r19],[@zoi190666r20],[@zoi190666r21],[@zoi190666r22],[@zoi190666r23],[@zoi190666r24],[@zoi190666r25],[@zoi190666r26],[@zoi190666r27],[@zoi190666r28],[@zoi190666r29],[@zoi190666r30],[@zoi190666r31],[@zoi190666r32],[@zoi190666r33],[@zoi190666r34],[@zoi190666r35],[@zoi190666r36],[@zoi190666r37],[@zoi190666r38],[@zoi190666r39],[@zoi190666r40],[@zoi190666r41],[@zoi190666r42],[@zoi190666r43],[@zoi190666r44],[@zoi190666r45],[@zoi190666r46],[@zoi190666r47],[@zoi190666r48],[@zoi190666r49],[@zoi190666r50],[@zoi190666r51],[@zoi190666r52],[@zoi190666r53],[@zoi190666r54],[@zoi190666r55],[@zoi190666r56],[@zoi190666r57],[@zoi190666r58],[@zoi190666r59],[@zoi190666r60],[@zoi190666r61],[@zoi190666r62],[@zoi190666r63],[@zoi190666r64],[@zoi190666r65],[@zoi190666r66],[@zoi190666r67],[@zoi190666r68],[@zoi190666r69],[@zoi190666r70],[@zoi190666r71],[@zoi190666r72],[@zoi190666r73],[@zoi190666r74],[@zoi190666r75],[@zoi190666r76],[@zoi190666r77],[@zoi190666r78]^ measured CDI incidence. Thirteen of those 66 studies^[@zoi190666r13],[@zoi190666r14],[@zoi190666r15],[@zoi190666r16],[@zoi190666r17],[@zoi190666r18],[@zoi190666r19],[@zoi190666r20],[@zoi190666r21],[@zoi190666r22],[@zoi190666r23],[@zoi190666r24],[@zoi190666r25]^ used patient-days as the denominator ([Table 1](#zoi190666t1){ref-type="table"}). Among these studies, the CDI incidence varied from 2.8 CDI cases per 10 000 patient-days^[@zoi190666r22]^ to 15.8 CDI cases per 10 000 patient-days.^[@zoi190666r20]^ Three studies^[@zoi190666r13],[@zoi190666r17],[@zoi190666r23]^ were conducted by the Centers for Disease Control and Prevention. Three studies^[@zoi190666r17],[@zoi190666r18],[@zoi190666r21]^ were done in New York State. One study^[@zoi190666r24]^ from Southern California found that the incidence of community-onset, health care facility (HCF)--associated CDI (11.1 cases per 10 000 patient-days) was almost 2-fold higher than that for HO, HCF-associated CDI (6.8 cases per 10 000 patient-days). The pooled incidence of HO-CDI among the 13 studies^[@zoi190666r13],[@zoi190666r14],[@zoi190666r15],[@zoi190666r16],[@zoi190666r17],[@zoi190666r18],[@zoi190666r19],[@zoi190666r20],[@zoi190666r21],[@zoi190666r22],[@zoi190666r23],[@zoi190666r24],[@zoi190666r25]^ ([Table 1](#zoi190666t1){ref-type="table"}) that used patient-days as the denominator was 8.3 CDI cases per 10 000 patient-days. Four studies^[@zoi190666r13],[@zoi190666r15],[@zoi190666r18],[@zoi190666r21]^ included more than 100 facilities.

###### Multicenter Studies (≥5 Sites) That Evaluated *Clostridium difficile* Infection Incidence Calculated Using Patient-Days

  Source                                    Data Set                                                                                                                      Study Period                            Facilities or Hospitals, No.         *C difficile* Definition                                                                                                                                                                Incidence
  ----------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------
  Archibald et al,^[@zoi190666r13]^ 2004    CDC's National Nosocomial Infections Surveillance                                                                             1987-2001                               90-340 Hospitals depending on year   CDC definition                                                                                                                                                                          Teaching hospital intensive care units, 5.1 cases/10 000 patient-days; nonteaching hospital intensive care units, 4.4 cases/10 000 patient-days
  Burger et al,^[@zoi190666r14]^ 2006       Veterans' Health Administration East Coast Infection Control Council hospitals                                                Q3 1999 to Q4 2002                      32                                   CDC definition                                                                                                                                                                          7.9 Cases/10 000 patient-days
  Campbell et al,^[@zoi190666r15]^ 2009     State of Ohio                                                                                                                 January 1, 2006, to December 31, 2006   210                                  *ICD-9* code, laboratory tests, clinical findings                                                                                                                                       6.4-7.9 Cases/10 000 patient-days
  Dubberke et al,^[@zoi190666r16]^ 2010     Hospitals in CDC Epicenter Network                                                                                            July 2000 to June 2006                  5                                    *C difficile* toxin assay results and the *ICD-9* code                                                                                                                                  HO, HCF--associated cases: 7.0 cases/10 000 patient-days in 2001 and 8.5 cases/10 000 patient-days in 2006
  Gase et al,^[@zoi190666r17]^ 2013         New York State National Healthcare Safety Network                                                                             July-December 2009                      30                                   Clinical findings, laboratory tests                                                                                                                                                     9.66 Cases/10 000 patient-days (95% CI, 9.21-10.1 cases/10 000 patient-days)
  Haley et al,^[@zoi190666r18]^ 2014        New York hospital discharge billing records                                                                                   2010                                    124                                  Clinical findings, laboratory tests                                                                                                                                                     11.6 Cases/10 000 patient-days
  Kim et al,^[@zoi190666r19]^ 2008          Pediatric Health Information System Database                                                                                  2001-2006                               22                                   *ICD-9*code, billing charge for *C difficile* toxin assay, and an initial dose of *C difficile* antibiotic therapy in the period of 1 d before to 2 d after *C difficile* toxin assay   2001, 4.4 Cases/10 000 patient-days; 2006, 6.5 cases/10 000 patient-days
  Kamboj et al,^[@zoi190666r20]^ 2012       Comprehensive Cancer Center's Infection Control Group Network of Patients with Cancer or Hematopoietic Stem Cell Transplant   2010-2011                               11                                   Laboratory tests and *C difficile* surveillance                                                                                                                                         HO *C difficile* infection, 15.8 cases/10 000 patient-days
  McDonald et al,^[@zoi190666r21]^ 2012     3 State-led programs (Illinois, Massachusetts, New York)                                                                      2008-2011                               711                                  Clinical findings, laboratory tests                                                                                                                                                     7.4 Cases/10 000 patient-days
  Miller et al,^[@zoi190666r22]^ 2011       Duke Infection Control Outreach Network                                                                                       2005-2009                               28                                   Infection preventionist evaluated surveillance or diagnosis                                                                                                                             2.8 Cases/10 000 patient-days
  Sohn et al,^[@zoi190666r23]^ 2005         Hospitals in CDC Epicenter Network                                                                                            2000-2003                               7                                    Clinical findings, laboratory tests, and CDC surveillance of *C difficile*                                                                                                              12.1 Cases/10 000 patient-days (mean range, 3.1-25.1 cases/patient-days); 7.4 cases/1000 admissions (mean range, 3.1-13.1 cases/1000 admissions)
  Tartof et al,^[@zoi190666r24]^ 2014       Kaiser Permanente Southern California health care system                                                                      2011-2012                               14                                   Laboratory tests: polymerase chain reaction                                                                                                                                             Community-onset, HCF-associated, 11.1 cases/10 000 patient-days; HO, HCF-associated, 6.8 cases/10 000 patient-days
  Zilberberg et al,^[@zoi190666r25]^ 2011   CareFusion clinical research database                                                                                         January 2007 to June 2008               85                                   Laboratory tests                                                                                                                                                                        6.3 Cases/10 000 patient-days

Abbreviations: CDC, Centers for Disease Control and Prevention; HCF, health care facility; HO, hospital onset; *ICD-9*, *International Classification of Diseases, Ninth Revision*; Q, quarter.

The definitions of *C difficile* used to identify cases varied. Three studies^[@zoi190666r17],[@zoi190666r18],[@zoi190666r21]^ used clinical findings and results of laboratory tests for *C difficile*, 3 studies^[@zoi190666r13],[@zoi190666r14],[@zoi190666r23]^ used the Centers for Disease Control and Prevention surveillance definition to identify *C difficile*, 2 studies^[@zoi190666r20],[@zoi190666r22]^ applied infection preventionist evaluations for *C difficile* surveillance, and 2 studies^[@zoi190666r24],[@zoi190666r25]^ used only results of laboratory tests for *C difficile*. The remaining studies used a variety of ways to identify CDI, including *International Classification of Diseases, Ninth Revision*(*ICD-9*) codes or other billing codes,^[@zoi190666r15],[@zoi190666r16],[@zoi190666r19]^ laboratory test results,^[@zoi190666r15],[@zoi190666r16],[@zoi190666r20],[@zoi190666r23]^ clinical findings,^[@zoi190666r15],[@zoi190666r23]^ and initial doses of *C difficile* antibiotic therapy.^[@zoi190666r19]^ When we examined incidence by time period, we found that the early studies from 2000 to 2008 had a range from 2.8 to 12.2 CDI cases per 10 000 patient-days, studies from 2008 to 2009 had a range from 6.3 to 9.6 CDI cases per 10 000 patient-days, and the later studies after 2010 reported a range from 6.8 to 15.8 CDI cases per 10 000 patient-days ([Table 1](#zoi190666t1){ref-type="table"}).

Incidence of CDI Calculated Using Person-Years (17 Studies) {#H2-6-ZOI190666}
-----------------------------------------------------------

Fourteen studies^[@zoi190666r26],[@zoi190666r27],[@zoi190666r28],[@zoi190666r29],[@zoi190666r30],[@zoi190666r31],[@zoi190666r32],[@zoi190666r33],[@zoi190666r34],[@zoi190666r35],[@zoi190666r36],[@zoi190666r37],[@zoi190666r38],[@zoi190666r39]^ included both inpatients and outpatients ([Table 2](#zoi190666t2){ref-type="table"}), reflected in a denominator of person-years in 8 studies.^[@zoi190666r27],[@zoi190666r28],[@zoi190666r29],[@zoi190666r30],[@zoi190666r32],[@zoi190666r34],[@zoi190666r36],[@zoi190666r39]^ Seven of those 14 studies^[@zoi190666r27],[@zoi190666r28],[@zoi190666r29],[@zoi190666r30],[@zoi190666r32],[@zoi190666r34],[@zoi190666r39]^ used only *ICD-9*codes to define CDI. In a study^[@zoi190666r36]^ of adult and adolescent patients with HIV/AIDS that included more than 100 hospitals, during 10 years of study, the peak incidence of CDI was 9.59 cases per 1000 person-years among patients with clinical AIDS. A study^[@zoi190666r28]^ of the Armed Forces Health Surveillance Center in Maryland over the course of 12 years found the incidence of community-associated CDI to be 5.5 cases per 100 000 person-years. In a study^[@zoi190666r29]^ evaluating the annual incidence of CDI and multiply recurrent CDI per 1000 person-years, the incidences increased by 42.7% and 188.8%, respectively, during a decade (2001-2012) in the United States. In another study^[@zoi190666r30]^ with 12 years of data from 5 administrative databases, elderly people (ie, aged \>65 years) had a CDI rate of 677 cases per 100 000 person-years. In contrast, a managed-care organization in Colorado found that the CDI incidence in 2007 was 14.9 CDI cases per 10 000 patient-years.^[@zoi190666r32]^ These studies were too diverse to pool together into 1 estimate.

###### Multicenter Studies (≥5 Sites) That Evaluated *Clostridium difficile* Infection Incidence Calculated Using Person-Years

  Source                                                          Data Set                                                                                                                                                                                                                     Study Period   Facilities or Hospitals, No.                                                                                                                                                        *C difficile* Definition                                                                                                                                         Incidence
  --------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Denominator: geographic population (inpatient and outpatient)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  Chernak et al,^[@zoi190666r26]^ 2005                            Philadelphia, Pennsylvania, and surrounding 4 counties                                                                                                                                                                       2004-2005      Not stated                                                                                                                                                                          Clinical diagnosis                                                                                                                                               Community-associated, 7.6 cases/100 000 population
  Dubberke et al,^[@zoi190666r27]^ 2016                           Medicare Chronic Condition Warehouse (5% random sample)                                                                                                                                                                      2009           5% Random sample                                                                                                                                                                    *ICD-9*                                                                                                                                                          Overall incidence of CDI, 677 cases/100 000 persons
  Gutiérrez et al,^[@zoi190666r28]^ 2013                          Defense Medical Surveillance Center, Armed Forces Health Surveillance Center, US Department of Defense, Silver Spring, Maryland                                                                                              1998-2010      Not stated                                                                                                                                                                          *ICD-9*                                                                                                                                                          *C difficile--*associated disease incidence, 13.2 cases/100 000 person-years; community-associated, 5.5 cases/100 000 person-years; health care *C difficile*--associated disease, 1.3 cases/1000 hospitalizations
  Ma et al,^[@zoi190666r29]^ 2017                                 OptumInsight Clinformatics Database                                                                                                                                                                                          2001-2012      38 911 718 Commercially insured patients                                                                                                                                            *ICD-9*                                                                                                                                                          Annual incidence of CDI and multiply recurrent CDI per 1000 person-years increased by 42.7% (from 0.4408 to 0.6289 case) and 188.8% (from 0.0107 to 0.0309 case), respectively
  Olsen et al,^[@zoi190666r30]^ 2016                              5 Databases: Medicare 5% Sample, Healthcare Cost and Utilization Project State Inpatient Databases and the National Inpatient Sample, OptumInsight Retrospective Database, and Premier Perspective                           2000-2012      Not stated                                                                                                                                                                          *ICD-9*                                                                                                                                                          Adults aged \<65 y, 66.0 cases/100 000 person-years for OptumInsight Retrospective Database and 37.5 cases/100 000 person-years for State Inpatient Databases; adults aged \>65 y, 677 cases/100 000 person-years for Medicare and 383 cases/100 000 person-years for State Inpatient Databases
  Rabatsky-Ehr et al,^[@zoi190666r31]^ 2008                       Connecticut Department of Health reportable conditions surveillance system                                                                                                                                                   2006           28 Hospitals and US Census for Connecticut                                                                                                                                          Clinical findings, laboratory tests                                                                                                                              6.9 Cases/100 000 population
  Kuntz et al,^[@zoi190666r32]^ 2012                              Kaiser Permanente Colorado and Kaiser Permanente Northwest (both inpatient and outpatient)                                                                                                                                   2007           Not stated                                                                                                                                                                          *ICD-9* code and positive test result needing antibiotic dispensation                                                                                            14.9 Cases/10 000 patient-years; for women, 213 cases/100 000 enrollees aged 60-69 y, 420 cases/100 000 enrollees aged 70-79 y, and 795 cases/100 000 enrollees aged ≥80 y; for men, 167 cases/100 000 enrollees aged 60-69 y, 311 cases/100 000 enrollees aged 70-79 y, and 871 cases/100 000 enrollees aged ≥80 y
  Lessa et al,^[@zoi190666r33]^ 2014                              Centers for Disease Control and Prevention Emerging Infections Program                                                                                                                                                       2010           CDI surveillance in selected counties across 7 US states                                                                                                                            Laboratory test (nucleic acid amplification)                                                                                                                     Crude incidence varied by geographic area; community-associated, 30.7-41.3 cases/100 000 population; health care--associated, 58.5-94.8 cases/100 000 population
  Reveles et al,^[@zoi190666r34]^ 2017                            Veterans Affairs Informatics and Computing Infrastructure                                                                                                                                                                    2002-2014      150 VHA hospitals and 820 VHA clinics                                                                                                                                               *ICD-9* and positive test result for CDI                                                                                                                         Overall, 3.1 cases/10 000 VHA enrollees; 2002, 1.6 cases/10 000 VHA enrollees; 2013, 5.1 cases/10 000 VHA enrollees; 2014, 4.6 cases/10 000 VHA enrollees
  Rhee et al,^[@zoi190666r35]^ 2014                               Centers for Disease Control and Prevention Emerging Infections Program                                                                                                                                                       2010-2011      CDI surveillance in Monroe County, New York                                                                                                                                         Clinical diagnosis plus laboratory tests; enzyme immunoassay toxin or glutamate dehydrogenase with enzyme immunoassay toxin or nucleic acid amplification test   2010, 33.8 cases/100 000 population; 2011, 45.8 cases/100 000 population
  Sanchez et al,^[@zoi190666r36]^ 2005                            Adult or adolescent spectrum of HIV disease project (inpatient and outpatient)                                                                                                                                               1992-2002      \>100 Hospitals                                                                                                                                                                     Clinical findings, laboratory tests                                                                                                                              All patients with HIV or AIDS, 4.12 cases/1000 person-years; patients with immunologic AIDS, 2.10 cases/1000 person-years; patients with clinical AIDS, 9.59 cases/1000 person-years
  Troppy et al,^[@zoi190666r37]^ 2019                             3 Sources of data: Massachusetts Virtual Epidemiology Network, National Healthcare Safety Network, and 2010 US Census data in Massachusetts                                                                                  2016           Not stated                                                                                                                                                                          Laboratory tests                                                                                                                                                 132.5 Cases/100 000 population
  Wendt et al,^[@zoi190666r38]^ 2014                              Centers for Disease Control and Prevention Emerging Infections Program in selected counties in 10 US states (California, Colorado, Connecticut, Georgia, Minnesota, New York, Oregon, Tennessee, Maryland, and New Mexico)   2010-2011      Not stated                                                                                                                                                                          Infection preventionist evaluated surveillance or diagnosis                                                                                                      Of 944 pediatric CDI cases identified, 71% were in California; CDI incidence children was highest among children aged 1 y (66.3 cases/per 100 000)
  Young-Xu et al,^[@zoi190666r39]^ 2015                           VHA health care records                                                                                                                                                                                                      2009-2013      152 Hospitals                                                                                                                                                                       *ICD-9* and positive test for CDI                                                                                                                                Overall CDI rate increased by 8.4% from 193 episodes/100 000 patient-years in 2009 to 209 episodes/100 000 patient-years in 2013
  Denominator: geographic population (only inpatient)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Argamany et al,^[@zoi190666r40]^ 2015                           US National Hospital Discharge Survey                                                                                                                                                                                        2001-2010      National Hospital Discharge Survey data are collected manually or automatically by trained hospital staff, US Census Bureau staff, or National Center for Health Statistics staff   *ICD-9*                                                                                                                                                          Pediatric population: 1.2 CDI discharges/1000 total discharges
  Zilberberg et al,^[@zoi190666r41]^ 2008                         AHRQ National Inpatient Sample infant patients                                                                                                                                                                               2000-2005      Not stated                                                                                                                                                                          *ICD-9*                                                                                                                                                          2000, 2.8 Cases/10 000 hospitalizations in infants; 2005, 5.1 cases/10 000 hospitalizations in infants
  Zilberberg et al,^[@zoi190666r42]^ 2008                         AHRQ National Inpatient Sample adult patients                                                                                                                                                                                2000-2005      Not stated                                                                                                                                                                          *ICD-9*                                                                                                                                                          2000, 5.5 Cases/10 000 hospitalizations in adults; 2005, 11.2 cases/10 000 hospitalizations in adults

Abbreviations: AHRQ, Agency for Healthcare Research and Quality; CDI, *Clostridium difficile* infection; *ICD-9*, *International Classification of Diseases, Ninth Revision*; VHA, Veterans Health Administration.

Three studies^[@zoi190666r40],[@zoi190666r41],[@zoi190666r42]^ included only inpatients ([Table 2](#zoi190666t2){ref-type="table"}). Two of these studies^[@zoi190666r41],[@zoi190666r42]^ assessed the Agency for Healthcare Research and Quality (AHRQ) National Inpatient Sample (NIS). One evaluated infant patients from the AHRQ NIS cohort,^[@zoi190666r41]^ and the other study evaluated adult patients from the AHRQ NIS cohort.^[@zoi190666r42]^ Both studies documented substantial increases in CDI incidence between 2000 and 2005, from 2.8 to 5.1 cases per 10 000 hospitalizations, and from 5.5 to 11.2 cases per 10 000 hospitalizations, respectively.^[@zoi190666r41],[@zoi190666r42]^ The third study,^[@zoi190666r40]^ which was from the US National Hospital Discharge Survey between 2001 and 2010, found that the incidence of CDI in the pediatric population was 1.2 CDI discharges per 1000 total discharges.

Incident Cases of CDI (36 Studies) {#H2-7-ZOI190666}
----------------------------------

Twenty-six studies^[@zoi190666r43],[@zoi190666r44],[@zoi190666r45],[@zoi190666r46],[@zoi190666r47],[@zoi190666r48],[@zoi190666r49],[@zoi190666r50],[@zoi190666r51],[@zoi190666r52],[@zoi190666r53],[@zoi190666r54],[@zoi190666r55],[@zoi190666r56],[@zoi190666r57],[@zoi190666r58],[@zoi190666r59],[@zoi190666r60],[@zoi190666r61],[@zoi190666r62],[@zoi190666r63],[@zoi190666r64],[@zoi190666r65],[@zoi190666r66],[@zoi190666r67],[@zoi190666r68]^ documented HO-CDIs, which we assumed were incident cases ([Table 3](#zoi190666t3){ref-type="table"}). Of these studies, the AHRQ NIS was the main data set, represented by 10 included studies.^[@zoi190666r43],[@zoi190666r45],[@zoi190666r47],[@zoi190666r50],[@zoi190666r51],[@zoi190666r56],[@zoi190666r58],[@zoi190666r59],[@zoi190666r61],[@zoi190666r68]^ These studies assessed diverse patient populations with different comorbidities, including peripartum women^[@zoi190666r68]^ and patients with inflammatory bowel disease,^[@zoi190666r43]^ lymphoma,^[@zoi190666r45]^ leukemia,^[@zoi190666r58]^ subarachnoid hemorrhage treated with microsurgical or endovascular aneurysm repair,^[@zoi190666r47]^ chronic liver disease,^[@zoi190666r50]^ hematopoietic stem cell transplant,^[@zoi190666r51]^ megacolon,^[@zoi190666r56]^ or heart failure.^[@zoi190666r59]^ Thus, the results of these studies were also too diverse to pool together. One study^[@zoi190666r68]^ found that the CDI incidence among peripartum women increased from 0.36 cases per 10 000 in 1998 to 0.70 cases per 10 000 in 2006. The US National Hospital Discharge Survey database was represented in 6 included studies.^[@zoi190666r49],[@zoi190666r52],[@zoi190666r53],[@zoi190666r55],[@zoi190666r64],[@zoi190666r65]^ These studies also assessed diverse patient populations, including children^[@zoi190666r52]^ and adults with different comorbidities, such as cancer^[@zoi190666r49],[@zoi190666r52]^ and inflammatory bowel disease.^[@zoi190666r65]^ In 1 of these studies,^[@zoi190666r65]^ the overall incidence of HO-CDI was 369.8 cases per 10 000 hospitalizations for inflammatory bowel disease. In that same study,^[@zoi190666r65]^ the HO-CDI incidence was 445.6 cases per 10 000 hospitalizations for ulcerative colitis and 220.3 cases per 10 000 hospitalizations for Crohn disease.

###### Multicenter Studies (≥5 Sites) That Evaluated *Clostridium difficile* Infection Incidence Using Incident Cases

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Source                                     Data Set                                                                                                                                         Study Period                                                                                                                               Facilities or Hospitals, No.                                                                                                                                                    *C difficil*e Definition                      Incidence
  ------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  HO infections                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Barber et al,^[@zoi190666r43]^ 2018        AHRQ NIS patients with inflammatory bowel disease                                                                                                1998-2014                                                                                                                                  Approximately 1000 hospitals                                                                                                                                                    *ICD-9*                                       Incidence of HO-CDI, 7.8 cases/1000 hospitalizations in 1998 and 32.1 cases/ 1000 hospitalizations in 2014 among patients with Crohn disease, and 23.0 cases/1000 hospitalizations in 1998 and 84.7 cases/1000 hospitalizations in 2014 among patients with ulcerative colitis

  Barlam et al,^[@zoi190666r44]^ 2018        Truven Health Marketscan Commercial Claims and Encounters database                                                                               2011-2013                                                                                                                                  This database represents approximately 50 million covered lives (annually) for employed subscribers aged \<65 y and their dependents                                            *ICD-9*                                       4 080 597 Unique individuals aged 1-64 y were admitted to the hospital in 2011; 12 025 had ≥1 *C difficile* diagnosis and complete enrollment information for 2011 (12 025 / 4 080 597 = 0.29%)

  Bhandari et al,^[@zoi190666r45]^ 2018      AHRQ NIS database                                                                                                                                2007-2011                                                                                                                                  20% Stratified sample of US community hospitals                                                                                                                                 *ICD-9*                                       Incidence of HO-CDI was 2.13% among patients with lymphoma and 0.8% among patients without lymphoma

  Brown et al,^[@zoi190666r46]^ 2017         VA health care system                                                                                                                            January 2006- December 2012                                                                                                                131 Acute care facilities                                                                                                                                                       Laboratory tests                              15.6 CDI cases/10 000 person-days

  Dasenbrock et al,^[@zoi190666r47]^ 2016    AHRQ NIS patients with subarachnoid hemorrhage who underwent microsurgical or endovascular aneurysm repair                                       2002-2011                                                                                                                                  Approximately 1000 hospitals                                                                                                                                                    *ICD-9*                                       Incidence of HO-CDI was 1.9%

  Davis et al,^[@zoi190666r48]^ 2018         Electronic medical record of the health system                                                                                                   2014-2016                                                                                                                                  5-Hospital health system in Houston, Texas                                                                                                                                      Laboratory tests                              Incidence of HO-CDI was 1.52%

  Delgado et al,^[@zoi190666r49]^ 2017       US NHDS                                                                                                                                          2001-2010                                                                                                                                  Not stated                                                                                                                                                                      *ICD-9*                                       Incidence of HO-CDI was 8.6 cases/1000 cancer discharges

  Dotson et al,^[@zoi190666r50]^ 2018        AHRQ NIS patients with chronic liver disease                                                                                                     2009                                                                                                                                       Approximately 1000 hospitals                                                                                                                                                    *ICD-9*                                       Incidence of HO-CDI was 189.4 cases/10 000 discharges

  Guddati et al,^[@zoi190666r51]^ 2014       AHRQ NIS database                                                                                                                                2000-2009                                                                                                                                  20% Stratified sample of US community hospitals                                                                                                                                 *ICD-9*                                       Incidence of HO-CDI among hematopoietic stem cell transplant recipients was 4.7%; nontransplant discharges were 0.86 cases/100 hospitalized patients

  Gupta et al,^[@zoi190666r52]^ 2016         US NHDS                                                                                                                                          2005-2009                                                                                                                                  Not stated                                                                                                                                                                      *ICD-9*                                       Overall HO-CDI incidence in children was 33.5 cases/10 000 hospitalizations

  Gupta et al,^[@zoi190666r53]^ 2017         US NHDS                                                                                                                                          2001-2010                                                                                                                                  100 Hospitals                                                                                                                                                                   *ICD-9*                                       Incidence of HO-CDI in patients with cancer was 64.7 cases/10 000 discharges in 2001-2002 and 109.1 cases/10 000 discharges in 2009-2010

  Jiang et al,^[@zoi190666r54]^ 2013         Rhode Island Hospital Discharge Database                                                                                                         2010-2011                                                                                                                                  11 Hospitals                                                                                                                                                                    *ICD-9* excluding present on admission code   HO-CDI, 1211 infections among 225 999 discharges = 53.5 cases/10 000 discharges

  Khanna et al,^[@zoi190666r55]^ 2016        US NHDS                                                                                                                                          2005-2009                                                                                                                                  100 Hospitals                                                                                                                                                                   *ICD-9*                                       HO-CDI incidence was 77.8 cases/10 000 hospitalizations

  Kuy et al,^[@zoi190666r56]^ 2016           AHRQ NIS patients with both *C difficile* and megacolon                                                                                          2000-2010                                                                                                                                  Approximately 1000 hospitals                                                                                                                                                    *ICD-9*                                       Overall incidence of megacolon among all hospitalized patients was 0.02% from 2000 to 2010; percentage of cases of megacolon due to CDI was 3.61% in 2000 and 9.39% in 2010

  Lessa et al,^[@zoi190666r57]^ 2015         Centers for Disease Control and Prevention Emerging Infections Program                                                                           2011                                                                                                                                       10 Program sites across 34 counties                                                                                                                                             Laboratory tests                              453 000 Incident infections

  Luo et al,^[@zoi190666r58]^ 2015           AHRQ NIS patients with CDI with leukemia                                                                                                         2005-2011                                                                                                                                  Approximately 1000 hospitals                                                                                                                                                    *ICD-9*                                       Overall incidence of CDI among patients with leukemia, 3.4%; incidence of CDI among all hospitalized patients, 0.85%; incidence of CDI among patients with leukemia in 2005, 3.0%; incidence of CDI among patients with leukemia in 2011, 3.5%\

  Mamic et al,^[@zoi190666r59]^ 2016         AHRQ NIS database                                                                                                                                2012                                                                                                                                       20% Stratified sample of US community hospitals                                                                                                                                 *ICD-9*                                       HO-CDI incidence among patients with a discharge diagnosis of heart failure, 3.5%

  Miller et al,^[@zoi190666r60]^ 2016        Healthcare Cost and Utilization Project State Inpatient Database for California                                                                  2005-2011                                                                                                                                  480 Hospitals                                                                                                                                                                   *ICD-9*                                       Overall incidence of HO-CDI, 0.15 cases/100 patients

  Miller et al,^[@zoi190666r61]^ 2016        AHRQ NIS database                                                                                                                                2009-2011                                                                                                                                  480 Hospitals                                                                                                                                                                   *ICD-9*                                       HO-CDI incidence, 0.85 cases/100 patients in 2009, 0.89 cases/100 patients in 2010, and 0.99 cases/100 patients in 2011\

  Pant et al,^[@zoi190666r62]^ 2016          Kids' Inpatient Database (Healthcare Cost and Utilization Project)                                                                               2003-2012                                                                                                                                  Contains data from a variety of hospitals, including nonfederal, short-term, general, and special hospitals (including children's hospitals) accessible by the general public   *ICD-9*                                       Incidence rate of CDI increased from 24.0 to 58.0 cases/10 000 discharges per year (*P* \< .001) across all age groups, with the greatest increase in children aged ≥15 y

  Pant et al,^[@zoi190666r63]^ 2016          2012                                                                                                                                             Rate of CDI infection in children without solid-organ transplant was 0.6% and was greater (3.6%) in children with solid-organ transplant                                                                                                                                                                                                                                 

  Reveles et al,^[@zoi190666r64]^ 2014       US NHDS of hospitalized adults                                                                                                                   2001-2010                                                                                                                                  100 Hospitals                                                                                                                                                                   *ICD-9*                                       Incidence of HO-CDI, 4.5 cases/1000 adult discharges in 2001 and 8.2 cases/1000 adult discharges in 2010

  Saffouri et al,^[@zoi190666r65]^ 2017      US NHDS inflammatory bowel disease hospitalizations                                                                                              2005-2009                                                                                                                                  100 Hospitals                                                                                                                                                                   *ICD-9*                                       Overall incidence of HO-CDI was 369.8 cases/10 000 inflammatory bowel disease hospitalizations; HO-CDI incidence was 445.6 cases/10 000 ulcerative colitis hospitalizations and 220.3 cases/10 000 Crohn disease hospitalizations

  Sammons et al,^[@zoi190666r66]^ 2013       Pediatric Health Information System Database                                                                                                     2006-2011                                                                                                                                  41 Pediatric hospitals                                                                                                                                                          *ICD-9* and positive test for CDI             5107 Cases/693 516 patients; 73.6 cases/10 000 patients

  Murphy et al,^[@zoi190666r67]^ 2012        California hospital discharge data                                                                                                               2000-2007                                                                                                                                  29 Hospitals                                                                                                                                                                    *ICD-9*                                       28.7 Cases/10 000 admissions in 2000 and 52.2 cases/10 000 admissions in 2007

  Kuntz et al,^[@zoi190666r68]^ 2010         AHRQ NIS women hospitalized for childbirth and delivery                                                                                          1998-2006                                                                                                                                  20% Stratified sample of discharges from nonfederal acute care hospitals                                                                                                        *ICD-9*                                       CDI incidence ranged from 0.36 CDI cases/10 000 peripartum women in 1998 to 0.70 CDI cases/10 000 peripartum women in 2006

  Denominator: surgical patients                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Aquina et al,^[@zoi190666r69]^ 2016        Statewide Planning and Research Cooperative System (a hospital discharge database by the New York Department of Health)                          2005-2013                                                                                                                                  Patient-level data for all hospital admissions, ambulatory surgery procedures, and emergency department visits within New York State                                            *ICD-9*                                       22 Cases of CDI/1000 discharges

  Bovonratwet et al,^[@zoi190666r70]^ 2018   American College of Surgeons National Surgical Quality Improvement Program database                                                              2015                                                                                                                                       500 Institutions                                                                                                                                                                Clinical findings, laboratory tests           0.11% of the population had postoperative CDI

  Bovonratwet et al,^[@zoi190666r71]^ 2018   American College of Surgeons National Surgical Quality Improvement Program database                                                              2015                                                                                                                                       500 Institutions                                                                                                                                                                Clinical findings, laboratory tests           A total of 73 patients had *C difficile* colitis, generating an incidence of 1.05% (adult elderly, surgical patients \[hip fracture\])

  Bovonratwet et al,^[@zoi190666r72]^ 2018   The incidence of *C difficile* colitis was 0.10% (adult nonelderly and elderly, surgical patients \[hip and knee arthroplasty\])                                                                                                                                                                                                                                                                                                                                                                                          

  Delanois et al,^[@zoi190666r73]^ 2018      AHRQ NIS database                                                                                                                                2009-2013                                                                                                                                  Not stated                                                                                                                                                                      *ICD-9*                                       After revision total hip arthroplasty, 1.7% of patients had postoperative CDI

  Englesbe et al,^[@zoi190666r74]^ 2010      Michigan Surgical Quality Collaborative and American College of Surgeons-National Surgical Quality Improvement Program on colectomy operations   2007-2009                                                                                                                                  24 Hospitals                                                                                                                                                                    Not stated                                    Among patients undergoing colectomies who received nonabsorbable antibiotics for bowel preparation, 1.9% had postoperative CDI; among patients undergoing colectomies who did not receive nonabsorbable antibiotics for bowel preparation, 3% had postoperative CDI

  Lesperance et al,^[@zoi190666r75]^ 2011    AHRQ NIS patients who underwent elective colon resections                                                                                        2004-2006                                                                                                                                  Approximately 1000 hospitals                                                                                                                                                    *ICD-9*                                       Overall, 1.4%; 2004, 1.31%; 2005, 1.45%; 2006, 1.67%

  Guzman et al,^[@zoi190666r76]^ 2016        AHRQ NIS patients who underwent cervical spine surgery                                                                                           2002-2011                                                                                                                                  Approximately 1000 hospitals                                                                                                                                                    *ICD-9*                                       Overall incidence of CDI in postoperative cervical spine surgery hospitalizations, 0.08%; in 2011, 0.14%

  Gwam et al,^[@zoi190666r77]^ 2018          AHRQ NIS database                                                                                                                                2009-2013                                                                                                                                  Not stated                                                                                                                                                                      *ICD-9*                                       Incidence of CDI after revision total knee arthroplasty, 1.0%

  Maltenfort et al,^[@zoi190666r78]^ 2013    AHRQ NIS database                                                                                                                                2002-2010                                                                                                                                  Not stated                                                                                                                                                                      *ICD-9*                                       Incidence of *C difficile* remained \<0.6% during the study period
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: AHRQ, Agency for Healthcare Research and Quality; CDI, *Clostridium difficile* infection; HO, hospital onset; *ICD-9*, *International Classification of Diseases, Ninth Revision*; NHDS, National Hospital Discharge Survey; NIS, National Inpatient Sample; VA, Veterans Affairs.

Ten studies^[@zoi190666r69],[@zoi190666r70],[@zoi190666r71],[@zoi190666r72],[@zoi190666r73],[@zoi190666r74],[@zoi190666r75],[@zoi190666r76],[@zoi190666r77],[@zoi190666r78]^ evaluated surgical patients ([Table 3](#zoi190666t3){ref-type="table"}), and, thus, we assumed that the CDI cases were incident cases. Five studies^[@zoi190666r73],[@zoi190666r75],[@zoi190666r76],[@zoi190666r77],[@zoi190666r78]^ used data from AHRQ NIS. These AHRQ NIS studies analyzed a variety of surgical procedures, including spine surgery^[@zoi190666r76]^; hip,^[@zoi190666r73]^ knee,^[@zoi190666r77]^ or lower-extremity^[@zoi190666r78]^ arthroplasty; and elective colon resections.^[@zoi190666r75]^ One of them had CDI occurring in 1.4% of patients, for a rate of 144.99 cases of *C difficile* colitis per 10 000 elective colon resections, and the incidence increased from 1.31% in 2004 to 1.67% in 2006.^[@zoi190666r75]^

LOS Associated With CDI (20 Studies) {#H2-8-ZOI190666}
------------------------------------

Twenty studies^[@zoi190666r16],[@zoi190666r54],[@zoi190666r66],[@zoi190666r79],[@zoi190666r80],[@zoi190666r81],[@zoi190666r82],[@zoi190666r83],[@zoi190666r84],[@zoi190666r85],[@zoi190666r86],[@zoi190666r87],[@zoi190666r88],[@zoi190666r89],[@zoi190666r90],[@zoi190666r91],[@zoi190666r92],[@zoi190666r93],[@zoi190666r94]^ ([Table 4](#zoi190666t4){ref-type="table"}) evaluated CDI-associated LOS. Sixteen studies^[@zoi190666r54],[@zoi190666r66],[@zoi190666r79],[@zoi190666r80],[@zoi190666r81],[@zoi190666r82],[@zoi190666r83],[@zoi190666r84],[@zoi190666r85],[@zoi190666r86],[@zoi190666r87],[@zoi190666r88],[@zoi190666r89],[@zoi190666r92],[@zoi190666r94],[@zoi190666r95]^ used propensity score matching to evaluate LOS associated with CDI, 2 studies^[@zoi190666r16],[@zoi190666r93]^ used postinfection LOS, 1 study^[@zoi190666r90]^ matched on LOS from admission until either positive *C difficile* test results or discharge, and 1 study^[@zoi190666r91]^ accounted for time to infection using a multistate model. Also, one of the propensity score matched--studies applied multistate modeling to account for timing of infection.^[@zoi190666r88]^ Pediatric patients were included in 3 of these studies.^[@zoi190666r66],[@zoi190666r86],[@zoi190666r87]^

###### Length of Stay Associated With *Clostridium difficile* Infection Among Studies That Used Appropriate Methods[^a^](#zoi190666t4n1){ref-type="table-fn"}

  Source                                    Data Set                                                                                              Study Period                    Patient Population                                                                                                                                                                                                                Facilities or Hospitals, No.       LOS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Method                                                                                 Downs and Black Score[^b^](#zoi190666t4n2){ref-type="table-fn"}
  ----------------------------------------- ----------------------------------------------------------------------------------------------------- ------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- -----------------------------------------------------------------
  Campbell et al,^[@zoi190666r79]^ 2013     Cerner Health Facts Electronic Health Record Database                                                 2005-2011                       Hospitalized adults at high risk for poor outcomes including those aged \>65 y, those with complex conditions or chronic diseases (renal disease, cancer, inflammatory bowel disease) and those with concomitant antibiotic use   74                                 Among patients aged \>65 y with HO-CDI, mean 19.10 d; among patients without CDI aged \>65 y, mean, 16.06 d; mean difference, 3.04 d (95% CI, 1.44-4.63 d)                                                                                                                                                                                                                                                                                                                                                 Propensity score matched including matching on preinfection LOS                        17
  Drozd et al,^[@zoi190666r80]^ 2015        Medicare Standard Analytic Files                                                                      2009-2010                       Inpatients                                                                                                                                                                                                                        5% Random sample of Medicare       Among patients with CDI, mean, 7.0 d; among patients without CDI, mean, 3.8 d; mean difference, 3.2 d                                                                                                                                                                                                                                                                                                                                                                                                      Propensity score matched                                                               17
  Dubberke et al,^[@zoi190666r81]^ 2008     Barnes-Jewish Hospital                                                                                2003                            Inpatients                                                                                                                                                                                                                        1                                  Among patients with CDI, median, 9.6 d; among patients without CDI, median, 5.8 d; attributable median difference, 2.8 d                                                                                                                                                                                                                                                                                                                                                                                   Propensity score matched                                                               15
  Dubberke et al,^[@zoi190666r16]^ 2010     Hospitals in Centers for Disease Control and Prevention Epicenter Network                             July 2000 to June 2006          Hospitalized adults                                                                                                                                                                                                               5 Hospitals                        Community-onset, patients with community-associated CDI, median, 5 d; patients with community-onset HCF-associated CDI (study hospital), median, 6 d; patients with community-onset HCF-associated CDI (other hospital), median, 8 d                                                                                                                                                                                                                                                                       Postinfection LOS                                                                      13
  Egorova et al,^[@zoi190666r82]^ 2015      AHRQ NIS database                                                                                     2000-2011                       Patients included in the Nationwide Inpatient Sample                                                                                                                                                                              20% of US Hospitals                Among patients with CDI, median (IQR), 15 (9-25) d; among patients without CDI, median (IQR), 8.3 (4.6-13.6) d; attributable median difference, 6.7 d                                                                                                                                                                                                                                                                                                                                                      Propensity score matched                                                               17
  Gabriel et al,^[@zoi190666r83]^ 2018      University of California Irvine Trauma Database                                                       2014-2016                       CDI in hospitalized adult trauma patients                                                                                                                                                                                         1                                  Odds ratio, 1.39; 95% CI, 1.16-1.66                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Propensity score matched                                                               15
  Jiang et al,^[@zoi190666r54]^ 2013        Rhode Island Hospital Discharge Database                                                              2010-2011                       Hospitalized adults; evaluated health care--onset CDI                                                                                                                                                                             11                                 Among patients with CDI, mean (SD), 18.9 (21.7) d; among patients without CDI, mean (SD), 8.6 (11.3) d; mean difference, 10.3 d                                                                                                                                                                                                                                                                                                                                                                            Propensity score matched                                                               15
  Li et al,^[@zoi190666r84]^ 2016           Veterans Affairs Surgical Quality Improvement Program database and Decision Support System pharmacy   2009-2013                       Postoperative adult patients                                                                                                                                                                                                      134                                Among patients with CDI, mean (SD), 15.6 (19.5) d; among patients without CDI, mean (SD), 8.1 (12.6) d; mean difference, 7.5 d                                                                                                                                                                                                                                                                                                                                                                             Propensity score matched                                                               18
  Magee et al,^[@zoi190666r85]^ 2015        Discharges from Premier database                                                                      2009-2011                       Inpatients                                                                                                                                                                                                                        Geographically diverse hospitals   Among patients with CDI mean (SD), 14.4 (18.3) d; among patients without CDI, mean (SD), 8.7 (15.6) d; mean difference, 5.7 d                                                                                                                                                                                                                                                                                                                                                                              Propensity score matched                                                               17
  Mehrotra et al,^[@zoi190666r86]^ 2017     AHRQ Kids' Inpatient Database                                                                         2012                            Pediatric inpatients                                                                                                                                                                                                              2500-4100 Hospitals/y              Among patients with CDI mean, 9.4 d (95% CI, 9.1-9.6 d); among patients without CDI, mean, 5.4 d (95% CI, 5.3-5.6 d); mean difference, 3.9 d                                                                                                                                                                                                                                                                                                                                                               Propensity score matched                                                               17
  Nylund et al,^[@zoi190666r87]^ 2011       Healthcare Cost and Utilization Project Kids' Inpatient Database                                      1997, 2000, 2003, 2006          Pediatric patients                                                                                                                                                                                                                Not stated                         Odds ratio, 4.34; 95% CI, 3.97-4.83                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Propensity score matched                                                               19
  Pak et al,^[@zoi190666r88]^ 2017          Mount Sinai Hospital Electronic Medical Record                                                        2009-2015                       Adult inpatients                                                                                                                                                                                                                  1                                  Median difference by case definition: *ICD-9* code, 3.1 d (95% CI, 2.2-3.9 d); positive toxin enzyme immunoassay, 10.1 d (95% CI, 7.3-12.2 d); positive toxin polymerase chain reaction, 6.6 d (95% CI, 5.0-8.1 d); either toxin assay, 7.2 d (95% CI, 5.8-8.3 d); by any of these, 5.7 d (95% CI, 4.5-6.6 d); stratification by time to first positive toxin assay, 3.1 d (95% CI, 1.7-4.4 d); under the same case definition, the multistate model averaged an excess LOS of 3.3 d (95% CI, 2.6-4.0 d)   Propensity score matched plus multistate modeling to account for timing of infection   14
  Radcliff et al,^[@zoi190666r89]^ 2016     Texas Health Care Information Collection Inpatient Public Use Data Files                              2007-2011                       Inpatients                                                                                                                                                                                                                        Texas hospitals                    For 2007, among patients with CDI, mean, 19.0 d; among patients without CDI, mean, 9.7 d; mean difference: 9.3 d; for 2011, among patients with CDI, mean, 16.5 d; among patients without CDI, mean, 9.2 d; mean difference, 7.4 d                                                                                                                                                                                                                                                                         Propensity score matched                                                               12
  Sammons et al,^[@zoi190666r66]^ 2013      Pediatric Health Information System Database                                                          2006-2011                       Hospitalized children at 41 children's hospitals                                                                                                                                                                                  41                                 Among patients with HO-CDI, median (IQR), 23 d (12-44 d); among patients without CDI matched to patients with HO-CDI, median (IQR not stated), 4 d; median difference, 19 d; adjusted mean difference, 21.6 d (95% CI, 19.29-23.90 d)                                                                                                                                                                                                                                                                      Propensity score matched                                                               15
  Song et al,^[@zoi190666r90]^ 2008         Johns Hopkins Hospital                                                                                January 2000 to October 2005    Hospitalized adults patients                                                                                                                                                                                                      1                                  Among patients with CDI, median, 19 d; among patients without CDI, median, 18 d; adjusted difference, 13% increased LOS among patients with CDI                                                                                                                                                                                                                                                                                                                                                            Matched on LOS from admission to either positive *C difficile* test or discharge       15
  Stevens et al,^[@zoi190666r91]^ 2015      VA Healthcare System                                                                                  January 2005 to December 2012   Hospitalized adults patients                                                                                                                                                                                                      120 Acute care facilities          Among patients with CDI, mean (SD), 19.4 (31.7) d; among patients without CDI, mean (SD), 5.4 (8.4) d; mean difference, 14 d; multistate modeling estimated an attributable LOS of only 2.27 d (95% CI, 2.14-2.40 d)                                                                                                                                                                                                                                                                                       Multistate modeling to account for timing of infection                                 19
  Stewart et al,^[@zoi190666r92]^ 2011      AHRQ NIS database                                                                                     2007                            Patients included in the Nationwide Inpatient Sample; age unknown, assumed all ages                                                                                                                                               20% of US hospitals                Among patients with CDI, mean (SD), 13.0 (14) d; among patients without CDI mean (SD), 7.9 (9) d; mean difference, 5.1 d                                                                                                                                                                                                                                                                                                                                                                                   Propensity score matched                                                               17
  Stewart et al,^[@zoi190666r93]^ 2012      Pennsylvania State College of Medicine                                                                2004-2009                       Patients with and without hematologic malignancies who acquired CDI                                                                                                                                                               1                                  Postinfection LOS for patients with CDI with malignancies and receiving chemotherapy, mean (SD), 22.4 (23.2) d; postinfection LOS for patients with CDI without malignancies, mean (SD), 10.2 (10) d                                                                                                                                                                                                                                                                                                       Postinfection LOS                                                                      14
  Tabak et al,^[@zoi190666r94]^ 2013        CareFusion database of 6 Pennsylvania hospitals                                                       2007-2008                       Hospitalized patients                                                                                                                                                                                                             6                                  Among patients with CDI, mean (SD), 16.3 (14.2) d; among patients without CDI, mean (SD), 14.0 (11.9) d; attributable days, 2.4 (95% CI, 0.7-4.4; *P* \< .01)                                                                                                                                                                                                                                                                                                                                              Propensity score matched                                                               18
  Zilberberg et al,^[@zoi190666r95]^ 2009   AHRQ NIS database                                                                                     2005                            Hospitalized patients                                                                                                                                                                                                             Approximately 1000 hospitals       Patients with CDI had an independent increase in the hospital LOS by 6.1 d (95% CI, 4.9-7.4 d)                                                                                                                                                                                                                                                                                                                                                                                                             Propensity score matched                                                               16

Abbreviations: AHRQ, Agency for Healthcare Research and Quality; CDI, *Clostridium difficile* infection; HCF, health care facility; HO, hospital onset; *ICD-9*, *International Classification of Diseases, Ninth Revision*; IQR, interquartile range; LOS, length of stay; NIS, National Inpatient Sample; VA, Veterans' Affairs.

Methods include propensity score matching or postinfection LOS or matched on preinfection LOS or multistate modeling.

The Downs and Black scale measures study quality, with a score of 18 or higher indicating higher quality, and a maximum score of 28 possible.^[@zoi190666r10]^

Among the 13 propensity score--matched studies of adults, the CDI-associated mean difference in LOS (in days) between patients with CDI and patients who did not have CDI varied greatly from 3.0 days (95% CI, 1.44-4.63 days)^[@zoi190666r79]^ to 10.3 days.^[@zoi190666r54]^ Among the 3 pediatric propensity score--matched studies,^[@zoi190666r66],[@zoi190666r86],[@zoi190666r87]^ the highest CDI-associated mean difference in LOS (in days) was 21.6 days (95% CI, 19.29-23.90 days).^[@zoi190666r66]^

Among the studies that used multistate models to account for timing of infection, a study^[@zoi190666r91]^ performed in the Veterans Affairs health care system found that the magnitude of its estimated impact was smaller when methods were used to account for the time-varying nature of infection. That study estimated a CDI-attributable LOS of only 2.27 days (95% CI, 2.14-2.40 days).^[@zoi190666r91]^ The other study^[@zoi190666r88]^ that performed propensity score matching and used a multistate model converged on similar excess LOS estimates of 3.1 days (95% CI, 1.7-4.4 days) and 3.3 days (95% CI, 2.6-4.0 days), respectively.

Four studies^[@zoi190666r84],[@zoi190666r87],[@zoi190666r91],[@zoi190666r94]^ that evaluated LOS earned 18 or more points on the Downs and Black scale.^[@zoi190666r10]^ One study^[@zoi190666r91]^ also used multistate modeling. Another was also performed in the Veterans Affairs health care system^[@zoi190666r84],[@zoi190666r91]^ and found a mean difference between patients with and without CDI of 7.5 days.^[@zoi190666r84]^ One study^[@zoi190666r87]^ of pediatric patients found that those with CDI had a longer LOS (adjusted odds ratio, 4.34; 95% CI, 3.97-4.83). Another study^[@zoi190666r94]^ of adult patients in Pennsylvania hospitals showed an attributable hospital LOS difference of 2.4 days (95% CI, 0.7-4.4 days; *P* \< .01) between patients with and without CDI.

Discussion {#H1-4-ZOI190666}
==========

National epidemiological investigations have demonstrated recent marked increases in CDI in the United States.^[@zoi190666r34]^ Thus, a national public health response to this increase requires current estimates of the CDI incidence.^[@zoi190666r96],[@zoi190666r97],[@zoi190666r98]^ Our systematic review of the literature found that the CDI incidence varied by study and that the investigators used different denominators when they calculated the incidence for specific study populations. In our meta-analysis of studies that used patient-days as the denominator, we estimated the incidence of CDI in the United States to be 8.3 CDI cases per 10 000 patient-days.

Variation in CDI incidence may be due, in part, to advances in diagnostic technology and variations in diagnostic practices.^[@zoi190666r99],[@zoi190666r100],[@zoi190666r101]^ Nucleic acid amplification tests are more sensitive than traditional *C difficile* stool tests (eg, toxin enzyme immunoassay). Nucleic acid amplification tests have been used more frequently in clinical practice since 2009, when the first commercial polymerase chain reaction was approved by the US Food and Drug Administration.^[@zoi190666r102]^ The topic of CDI testing methods and risk adjustment is complex.^[@zoi190666r103],[@zoi190666r104]^ Concerns have been expressed about the adequacy of risk adjustment to account for different CDI testing methods (toxin enzyme immunoassay alone, polymerase chain reaction alone, toxin enzyme immunoassay plus glutamate dehydrogenase followed by polymerase chain reaction for discrepancies, polymerase chain reaction followed by toxin enzyme immunoassay, and other diagnostic options) across HCFs. The choice of testing methods substantially affects the performance of these testing algorithms.^[@zoi190666r99],[@zoi190666r100],[@zoi190666r101]^

In addition, the CDI incidence found by these studies likely varied because of the different database structures adopted by the various hospitals.^[@zoi190666r13],[@zoi190666r14],[@zoi190666r15],[@zoi190666r16],[@zoi190666r17],[@zoi190666r18],[@zoi190666r19],[@zoi190666r20],[@zoi190666r21],[@zoi190666r22],[@zoi190666r23],[@zoi190666r24],[@zoi190666r25],[@zoi190666r26],[@zoi190666r27],[@zoi190666r28],[@zoi190666r29],[@zoi190666r30],[@zoi190666r31],[@zoi190666r32],[@zoi190666r33],[@zoi190666r34],[@zoi190666r35],[@zoi190666r36],[@zoi190666r37],[@zoi190666r38],[@zoi190666r39],[@zoi190666r40],[@zoi190666r41],[@zoi190666r42],[@zoi190666r43],[@zoi190666r44],[@zoi190666r45],[@zoi190666r46],[@zoi190666r47],[@zoi190666r48],[@zoi190666r49],[@zoi190666r50],[@zoi190666r51],[@zoi190666r52],[@zoi190666r53],[@zoi190666r54],[@zoi190666r55],[@zoi190666r56],[@zoi190666r57],[@zoi190666r58],[@zoi190666r59],[@zoi190666r60],[@zoi190666r61],[@zoi190666r62],[@zoi190666r63],[@zoi190666r64],[@zoi190666r65],[@zoi190666r66],[@zoi190666r67],[@zoi190666r68],[@zoi190666r69],[@zoi190666r70],[@zoi190666r71],[@zoi190666r72],[@zoi190666r73],[@zoi190666r74],[@zoi190666r75],[@zoi190666r76],[@zoi190666r77],[@zoi190666r78]^ Some analyses were based on health care systems databases, but most used large infection control surveillance, state, or national discharge databases.^[@zoi190666r13],[@zoi190666r14],[@zoi190666r15],[@zoi190666r16],[@zoi190666r17],[@zoi190666r18],[@zoi190666r19],[@zoi190666r20],[@zoi190666r21],[@zoi190666r22],[@zoi190666r23],[@zoi190666r24],[@zoi190666r25]^ Beginning in January 2013, the Centers for Medicare & Medicaid Services began requiring public reporting of CDI rates via the National Healthcare Safety Network for those hospitals participating in the Inpatient Prospective Payment System.^[@zoi190666r64]^ Specifically, 1 study^[@zoi190666r29]^ demonstrated an increase in the annual incidence of CDI and multiply recurrent CDI per 1000 person-years by 42.7% and 188.8%, respectively, between 2001 and 2012. Another CDI surveillance study^[@zoi190666r33]^ in 7 US states reported an increase not only in community-associated CDI incidence rates but also an increase in health care--associated CDI incidence rates. Furthermore, CDI can complicate comorbid conditions and result in the need for additional hospital resources.^[@zoi190666r34]^ Included studies detected an increase in the CDI incidence in patients with inflammatory bowel disease,^[@zoi190666r43]^ patients with cancer,^[@zoi190666r52]^ those undergoing surgery,^[@zoi190666r75],[@zoi190666r76]^ and even infants.^[@zoi190666r41]^ The results of our systematic review of literature and meta-analysis emphasize the need to perform *C difficile* surveillance and direct resources to the prevention of CDI in order to reduce the incidence across the United States.

Limitations {#H2-9-ZOI190666}
-----------

This systematic literature review has some limitations. First, the results of systematic literature reviews and meta-analyses are only as valid as the results of the studies evaluated. Most studies included in this systematic literature review were of moderate-to-low quality and may have overestimated the outcomes. We need more high-quality studies so that we can accurately determine postinfection LOS, because LOS before the infection should not be attributed to *C difficile*.^[@zoi190666r5]^ Second, we included studies that used *ICD-9* codes to define CDI. The *ICD-9* codes are used for billing purposes and are not ideal for surveillance. However, a prior meta-analysis^[@zoi190666r105]^ found that the *ICD-9* code for *C difficile* had good sensitivity, specificity, positive predictive value, and negative predictive value compared with clinical definitions. Third, we only included studies conducted in the United States and published in English, which limits the external validity of this research. We used these inclusion criteria because our goal was to evaluate the burden of CDI in the United States. Future systematic literature reviews should be performed to evaluate this burden in other countries. Fourth, we found heterogeneity in all LOS-stratified analyses (eAppendix 2 and eTable in the [Supplement](#note-ZOI190666-1-s){ref-type="supplementary-material"}). We found that the higher-quality studies that used advanced statistical methods to attempt to account for time-dependent bias found lower CDI-attributable LOS compared with other studies that did not use advanced methods. In addition, our incidence estimates were derived from multicenter studies only. Incidence rates in small studies may be variable and subject to bias; thus, this criterion was established a priori to determine representative incidence rates. From incident cases of CDI (36 studies), we were unable to exclude recurrent and multiply recurrent CDI cases if the study did not exclude those cases. For this meta-analysis, we decided to calculate the incidence rate with studies with a similar denominator (patient-days), with a result of 8.3 CDI cases per 10 000 patient-days.

Conclusions {#H1-5-ZOI190666}
===========

Pooled estimates from the currently available literature suggest that *C difficile* is associated with a large burden on the US health care system. However, these estimates should be used with caution, and higher-quality studies should be completed to guide future evaluations of *C difficile* prevention and treatment interventions.
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